KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Interest Coverage Ratio (2018 - 2025)

Historic Interest Coverage Ratio for TherapeuticsMD (TXMD) over the last 12 years, with Q3 2025 value amounting to 287.33.

  • TherapeuticsMD's Interest Coverage Ratio rose 2398.59% to 287.33 in Q3 2025 from the same period last year, while for Sep 2025 it was 246.86, marking a year-over-year increase of 7041.86%. This contributed to the annual value of 2.42 for FY2021, which is 5557.78% up from last year.
  • As of Q3 2025, TherapeuticsMD's Interest Coverage Ratio stood at 287.33, which was up 2398.59% from 347.5 recorded in Q2 2025.
  • TherapeuticsMD's 5-year Interest Coverage Ratio high stood at 1.24 for Q1 2022, and its period low was 557.8 during Q2 2024.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 54.93 (2023), whereas its average is 170.91.
  • As far as peak fluctuations go, TherapeuticsMD's Interest Coverage Ratio surged by 6479.53% in 2021, and later crashed by 420062.14% in 2023.
  • Over the past 5 years, TherapeuticsMD's Interest Coverage Ratio (Quarter) stood at 4.67 in 2021, then surged by 73.45% to 1.24 in 2022, then crashed by 7047.55% to 88.65 in 2023, then crashed by 326.4% to 378.0 in 2024, then rose by 23.99% to 287.33 in 2025.
  • Its Interest Coverage Ratio was 287.33 in Q3 2025, compared to 347.5 in Q2 2025 and 435.5 in Q1 2025.